BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

754 related articles for article (PubMed ID: 2136903)

  • 1. Bacterial proteins that mediate the association of a defined subset of T cell receptor:CD4 complexes with class II MHC.
    Yagi J; Baron J; Buxser S; Janeway CA
    J Immunol; 1990 Feb; 144(3):892-901. PubMed ID: 2136903
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intercellular adhesion molecule-1 and leukocyte function-associated antigen-3 provide costimulation for superantigen-induced T lymphocyte proliferation in the absence of a specific presenting molecule.
    Lamphear JG; Stevens KR; Rich RR
    J Immunol; 1998 Jan; 160(2):615-23. PubMed ID: 9551895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of MHC class I-restricted CD8+ CTL by microbial T cell mitogens. Dependence upon MHC class II expression of the target cells and V beta usage of the responder T cells.
    Herrmann T; Maryanski JL; Romero P; Fleischer B; MacDonald HR
    J Immunol; 1990 Feb; 144(4):1181-6. PubMed ID: 1968075
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immune recognition and effector function in subsets of CD4 T cells.
    Janeway CA; Yagi J; Rojo J; Portoles P; Carding S; Luqman M; Bottomly K
    Princess Takamatsu Symp; 1988; 19():193-208. PubMed ID: 2908353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of T cell receptor V beta gene usage in primary mixed lymphocyte reactions: evidence for directive usage by different antigen-presenting cells and Mls-like determinants on T cell blasts.
    Larsson-Sciard EL; Spetz-Hagberg AL; Casrouge A; Kourilsky P
    Eur J Immunol; 1990 Jun; 20(6):1223-9. PubMed ID: 2142455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel HLA class II-independent TCR-mediated T cell activation mechanism is distinguished by the V beta specificity of the proliferating oligoclones and their capacity to generate interleukin-2.
    Dennig D; Yan Y; Ferguson K; O'Reilly RJ
    Cell Immunol; 1996 Aug; 171(2):200-10. PubMed ID: 8806788
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Control of T cell responses to staphylococcal enterotoxins by stimulator cell MHC class II polymorphism.
    Yagi JJ; Rath S; Janeway CA
    J Immunol; 1991 Aug; 147(4):1398-405. PubMed ID: 1907996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Presentation of superantigen by human T cell clones: a model of T-T cell interaction.
    Nisini R; Matricardi PM; Fattorossi A; Biselli R; D'Amelio R
    Eur J Immunol; 1992 Aug; 22(8):2033-9. PubMed ID: 1353448
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staphylococcal enterotoxin B induces an early and transient state of immunosuppression characterized by V beta-unrestricted T cell unresponsiveness and defective antigen-presenting cell functions.
    Muraille E; De Smedt T; Andris F; Pajak B; Armant M; Urbain J; Moser M; Leo O
    J Immunol; 1997 Mar; 158(6):2638-47. PubMed ID: 9058796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An evolutionary conserved mechanism of T cell activation by microbial toxins. Evidence for different affinities of T cell receptor-toxin interaction.
    Fleischer B; Gerardy-Schahn R; Metzroth B; Carrel S; Gerlach D; Köhler W
    J Immunol; 1991 Jan; 146(1):11-7. PubMed ID: 1670601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Variable influence of MHC polymorphism on the recognition of bacterial superantigens by T cells.
    Wen R; Blackman MA; Woodland DL
    J Immunol; 1995 Aug; 155(4):1884-92. PubMed ID: 7636239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staphylococcal enterotoxin-mediated human T-T cell interactions.
    Koning F; Rust C
    J Immunol; 1992 Jul; 149(1):317-22. PubMed ID: 1535087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human major histocompatibility complex class II-negative colon carcinoma cells present staphylococcal superantigens to cytotoxic T lymphocytes: evidence for a novel enterotoxin receptor.
    Dohlsten M; Hedlund G; Segren S; Lando PA; Herrmann T; Kelly AP; Kalland T
    Eur J Immunol; 1991 May; 21(5):1229-33. PubMed ID: 1645269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CD4 and CD8 accessory molecules function through interactions with major histocompatibility complex molecules which are not directly associated with the T cell receptor-antigen complex.
    Lustgarten J; Waks T; Eshhar Z
    Eur J Immunol; 1991 Oct; 21(10):2507-15. PubMed ID: 1915555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of class II molecules in Mls 1a recognition by CD4+ T cells is independent of the CD4 molecule.
    Borrero H; Collazo L; Macphail S
    Cell Immunol; 1993 Dec; 152(2):594-604. PubMed ID: 7903065
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of bispecific heteroconjugated antibodies (anti-T cell antigen receptor x anti-MHC class II) to study activation of T cells with a full length or truncated antigen receptor zeta-chain.
    Wu S; Yang Y; Sadegh-Nasseri S; Ashwell JD
    J Immunol; 1993 Mar; 150(6):2211-21. PubMed ID: 8450208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Participation of L3T4 in T cell activation in the absence of class II major histocompatibility complex antigens. Inhibition by anti-L3T4 antibodies is a function both of epitope density and mode of presentation of anti-receptor antibody.
    Owens T; Fazekas de St Groth B
    J Immunol; 1987 Apr; 138(8):2402-9. PubMed ID: 2435798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proliferation of human T lymphocytes induced with superantigens is not dependent on costimulation by the CD28 counter-receptor B7.
    Damle NK; Klussman K; Leytze G; Linsley PS
    J Immunol; 1993 Feb; 150(3):726-35. PubMed ID: 7678619
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human intestinal V delta 1+ T cells obtained from patients with colon cancer respond exclusively to SEB but not to SEA.
    Maeurer M; Zitvogel L; Elder E; Storkus WJ; Lotze MT
    Nat Immun; 1995 Apr; 14(4):188-97. PubMed ID: 8696008
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transient T and B cell activation after neonatal induction of tolerance to MHC class II or Mls alloantigens.
    Schurmans S; Brighouse G; Kramer G; Wen L; Izui S; Merino J; Lambert PH
    J Immunol; 1991 Apr; 146(7):2152-60. PubMed ID: 1672344
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.